1. Home
  2. NSPR vs XPL Comparison

NSPR vs XPL Comparison

Compare NSPR & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.74

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

Logo Solitario Resources Corp.

XPL

Solitario Resources Corp.

HOLD

Current Price

$0.81

Market Cap

74.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
XPL
Founded
2005
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
74.8M
IPO Year
2009
2000

Fundamental Metrics

Financial Performance
Metric
NSPR
XPL
Price
$0.74
$0.81
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.00
$1.20
AVG Volume (30 Days)
156.2K
248.7K
Earning Date
05-04-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.86
EPS
N/A
N/A
Revenue
$2,310,000.00
N/A
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.54
52 Week High
$2.93
$0.98

Technical Indicators

Market Signals
Indicator
NSPR
XPL
Relative Strength Index (RSI) 29.27 44.62
Support Level N/A $0.68
Resistance Level $1.04 $0.81
Average True Range (ATR) 0.09 0.03
MACD -0.01 -0.01
Stochastic Oscillator 12.66 38.27

Price Performance

Historical Comparison
NSPR
XPL

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About XPL Solitario Resources Corp.

Solitario Resources Corp is an exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. Its core mineral property assets are: the Florida Canyon zinc project in Peru, the Lik zinc project in Alaska, and the Golden Crest project in South Dakota. Additionally, Solitario holds an interest in the Chambara project in Peru and also has two early-stage projects, the Cat Creek project and the Bright Angel project in Colorado. The company is conducting mineral exploration on its Golden Crest project, the Cat Creek project, and the Bright Angel project on its own.

Share on Social Networks: